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Abstract
Objective and Method: Cervical cancer is the third most common cancer affecting women worldwide and it is an important
cause of death, especially in developing countries. Cervical cancer is caused by human papillomavirus (HPV) and can be
prevented by HPV vaccine. The challenge is to expand vaccine availability to countries where it is most needed. In 2008
Peru’s Ministry of Health implemented a demonstration project involving 5th grade girls in primary schools in the Piura
region. We designed and conducted a qualitative study of the decision-making process among parents of girls, and
developed a conceptual model describing the process of HPV vaccine acceptance.
Results: We found a nonlinear HPV decision-making process that evolved over time. Initially, the vaccine’s newness, the
requirement of written consent, and provision of information were important. If information was sufficient and provided by
credible sources, many parents accepted the vaccine. Later, after obtaining additional information from teachers, health
personnel, and other trusted sources, more parents accepted vaccination. An understanding of the issues surrounding the
vaccine developed, parents overcome fears and rumors, and engaged in family negotiations–including hearing the girl’s
voice in the decision-making process. The concept of prevention (cancer as danger, future health, and trust in vaccines)
combined with pragmatic factors (no cost, available at school) and the credibility of the offer (information in the media,
recommendation of respected authority figure) were central to motivations that led parents to decide to vaccinate their
daughters. A lack of confidence in the health system was the primary inhibitor of vaccine acceptance.
Conclusions: Health personnel and teachers are credible sources of information and can provide important support to HPV
vaccination campaigns.
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Introduction
Cancer of the cervis is the third most common cancer affecting
women worldwide. Cervical c is preventable but continues to
cause the deaths of more than 270,000 women worldwide each
year [1], of whom over 85 percent live in developing countries
where existing programs to detect and provide timely treatment do
not reach or are beyond the means of most women [1,2]. Each
year in Peru, cancer of the cervix is responsible for the deaths of an
estimated 2,098 women [1] and is the most common cause of
mortality among women 25 to 44 years old [3].
Two strains of human papillomavirus (HPV), types 16 and 18,
account for about 70 percent of cervical cancers [4], approxi-
mately 90 percent of anal cancers, and a smaller subset (,50
percent) of other cancers, e.g., oropharyngeal, penile, vaginal, and
vulvar [5]. Vaccines against the two most common HPV types, 16
and 18, have proven safe and efficacious [6,7] in preventing
precancerous lesions in HPV-naive girls and women. Prophylactic
vaccination targeting these genotypes is expected to result in
significant reductions in the burden of cervical cancer and other
cancers associated with these genotypes, provided that these
vaccination programs can achieve significant coverage of the
target population [8].
New vaccine adoption has taken more time in lower-resource
settings: hepatitis B virus vaccine adoption in low-income countries
took nearly 20 years, twice as long as in high-income countries [9].
Vaccine price is often a key factor in vaccine decision-making [10],
though this may be less true for countries eligible for subsidized
vaccine through the GAVI Alliance. Prior to widespread HPV
vaccine introduction, speculation about potential significant
adoption barriers focused on several issues: the target age group
was outside the routine infant immunization schedule, the vaccine
was for girls only, the vaccine protected against a sexually
transmitted virus, and the benefits of vaccination were long term
rather than immediate [11,12].
Peru’s Ministry of Health implemented an HPV vaccine
demonstration project to study the issues necessary to make
informed decisions about the introduction of the vaccine into
the national immunization strategy. This project implemented
HPV vaccination in 2008 to girls aged nine years or older in
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grade 5 of state and private primary schools in a predefined
area of the region of Piura that included rural, urban, and peri-
urban locations. The project used existing health and education
systems and structures at local and regional levels for
community sensitization and mobilization, vaccine administra-
tion, delivery, and cold chain maintenance, and monitoring and
supervision [13]. The immunization program in Peru is well
established and nearly universally recognized at the community
level.
School-based vaccination programs for HPV may bring
additional challenges including informing parents and girls and
coordinating with the educational system, particularly teachers.
The dynamic between opportunity, information, authorization,
and informed consent for HPV vaccination in schools is a balance
that depends on many circumstances, and one that has been
under-investigated in studies to date [14]. To explore this
dynamic, we studied the decision-making process among parents
of girls eligible for HPV vaccination in Peru and developed
a conceptual model describing the process of vaccine acceptance.
Methods
We designed a qualitative descriptive study of HPV vaccine
acceptability and decision-making among parents of girls eligible
for vaccination. We selected schools that would capture the
diversity of situations at the school level within the area that
implemented HPV vaccinations.
Ethics Statement
We obtained verbal consent from all parents who agreed to
be interviewed for this study. Researchers read the scripted
verbal consent exactly as written so that the process was
standardized for all persons invited to participate in the study.
Research staff signed all verbal consent forms after verbal
consent was obtained to document the completed process and
agreement of individual parents to participate. Transcribed tape
recordings of each interview were assigned a unique identifier to
maintain confidentiality. All data were kept in secure files, and
computerized records were password protected with access
limited to research staff.
This study and its ethics procedures were approved by the
research ethics committees of PATH in the United States and the
Instituto de Investigacio´n Nutricional in Peru.
Sampling Process and Participants
In close collaboration with regional ministry of health staff in
charge of immunization, we selected 12 schools–six in urban areas
and six in rural areas–where HPV vaccination had been carried
out (Table 1). The goal was to represent diversity not only in rural
and urban populations, but also in factors such as affiliation with
health facilities, high and low coverage of HPV vaccine at first
dose (as a surrogate measure of successful programs and those that
experienced challenges), when HPV vaccination was first in-
troduced, and size of the affiliated health facility (including
hospitals).
Within each of the 12 participating schools, we selected and
interviewed parents of two girls who received all three doses of
HPV vaccinations and parents of two girls who were not
vaccinated with HPV vaccine. The total sample size was 48
parents. We asked teachers to suggest parents who were likely to
collaborate and share their experience of acceptance or refusal of
the vaccine. They received invitations inviting them to participate
in the study.
Data Collection, Management, and Analysis
In-depth interviews were conducted with each parent by
qualitative researchers with experience in anthropological in-
terview methods. The guided interview covered the HPV
vaccination program, educational and promotional materials and
activities, method of learning about the program, opinion about
the implementation of the vaccination program, factors that
influenced acceptance (or nonacceptance), and suggestions for
program improvements.
The in-depth interviews were recorded and then transcribed
into thematic matrixes generally retaining the textual expression of
the interviewee. Each thematic matrix was considered in relation
to the others to develop an integrated idea of the conditions and
factors that dealt with the parents’ acceptance and nonacceptance
of the HPV vaccine. This data analysis involved the reconstruction
or understanding of the points of view of the parents, identifying
the differences, similarities, and patterns within urban and rural
environments. We separately analyzed the data that supported
acceptance of the vaccine and the decision-making process and the
data related to nonacceptance. We used quotations to reinforce
the data analyzed and developed a conceptual image to
summarize our main findings [15].
Results
Dynamic Decision-making Process for HPV Vaccine
We observed a nonlinear decision-making process among
parents that evolved over time. The decision-making was
influenced by the context–particularly the way in which vaccina-
tion was offered, the follow-up by the health personnel, the
commitment shown by the teaching staff, and the inter-relatedness
of these elements. The parents and the girl made the decision,
which was influenced by others.
We identified at least two phases in this process: the first
reaction and preliminary decision, and the second phase during
which others influenced the final decision (Figure 1). These phases
were relevant for both parents who accepted and those who did
not accept HPV vaccine for their daughters. In the first phase, the
newness of the vaccine and the unusual requirement of written
consent from the parents were of particular importance. In the
face of a new vaccine and a new modality of providing a vaccine
(only to girls in grade 5 and with a signed informed consent), the
process of decision-making signified a process of acquiring
confidence in the midst of rumors and negative comments about
the vaccines. The information that parents received about the
disease and the vaccine allowed for a preliminary positioning, but
in many instances was not sufficient for making a decision. If the
information provided early-on, specifically to parents, was
sufficient, and if those who provided the information (teachers or
health personnel) had good credibility, many parents accepted the
vaccination. This was particularly true in rural areas, and in urban
schools with a positive previous experience between parents and
teachers or between health personnel and parents.
In the second phase, the activities implemented by teachers and
health personnel and information parents and girls found from
other sources allowed them to change their minds. It was a process
of developing a better understanding of the issues surrounding the
vaccine and cervical cancer, and overcoming fears, rumors, and
internal negotiation within the family. Nonetheless, many parents
looked for additional information about the vaccine through
avenues in which they had more confidence, or looked for the
agreement of the other parent. The girl’s own perspective also
played a role and generated a second phase in the decision-
making, particularly for families in urban areas.
Parental Acceptance of HPV Vaccine in Peru
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Table 1. Criteria used in the selection of health facilities in Piura.
Health network Health facility Urban
HPV vaccination
2007–2008
HPV vaccination
introduced in 2008 High coverage Low coverage
RED Bajo Piura CS Catacaos N N
CS Bernal N
CS La Legua*
RED Chulucanas Morropo´n Hospital Chulucanas N N
CS Morropo´n N N
CS Buenos Aires N
CS Yapatera N
CS Chalaco N
RED Huarmaca CS Huarmaca N N
RED Piura Castilla CS Pachitea N N N
Hospital Sta. Rosa N N
CS San Jose´ N N N
*Note: CS La Legua was selected based on its rural location.
doi:10.1371/journal.pone.0048017.t001
Figure 1. Conceptual model for parental decision-making for HPV vaccine in Piura. The figure illustrates how a variety of different
perceptions, experiences, knowledge, and attitudes provide a background context and influence a mother and/or father’s decision to vaccinate their
daughter. Divided into phases, the decision-making model demonstrates that if the basis of this decision is sufficiently positive, parents may proceed
to accept vaccination; however, if doubts remain, parents may seek further information or opinions and may modify their decision, crystallizing it into
refusal or acceptance. Model tested in northern Peru.
doi:10.1371/journal.pone.0048017.g001
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Factors that Favored Acceptance of HPV Vaccine
Community sensitization meetings with
parents. Immediately following meetings on cervical cancer
and the HPV vaccine, many parents agreed to give their consent.
This was true in both urban and rural areas, but particularly
pronounced in rural areas. Following what they heard in the
educational session or read in the informed consent and reflected
on at home, they felt that these meetings helped them understand
the issues, allowed them to ask questions, and encouraged them to
accept the vaccination. Nonetheless, afterwards they also asked
other people about their perspectives and talked to their husband
or wife. Some mentioned that they made a decision after the
informational meeting and felt a meeting like that should always
be offered. Some parents heard about the vaccine for the first time
at this meeting. Some parents said that their daughters talked to
them about what they had been taught about cervical cancer and
the HPV vaccine.
Vaccines are a well-recognized and accepted form of
prevention. The parents who accepted HPV vaccination said
they knew vaccines help prevent or cure illnesses, are given to
children, and represent financial savings for the family because the
children do not get those illnesses. Since families do not need to
invest in treating the associated illness, vaccines are considered
desirable for families with limited economic resources.
I think vaccines are good. If it’s a question of saving lives,
then the vaccine is welcome. I always support having my
daughters vaccinated. Right from the start I accepted it. As I
said before, I always have my daughters vaccinated because
it protects life. (urban mother)
HPV vaccine can prevent cervical cancer, a serious
illness. The parents who accepted the HPV vaccine also agreed
that cervical cancer is a frequent, serious, and deadly illness, and
that it causes a lot of suffering for women who develop it. They
also commented that treatment is costly and treatment services
either do not exist in the region or are not available to all women.
Those interviewed often described cases they knew personally,
which made it even more important to them to accept a pre-
ventative measure against this illness.
… and also because she benefited as well, due to the
illnesses, the cancer that’s currently affecting a lot of
people… it’s really advanced. There’s been an increase in
cases of cervical cancer. There are more cases than before
and the number is growing every day. So the need to protect
her made me see that the vaccine was a good thing. (rural
mother)
Teachers influenced the environment of decision-
making. Many parents also said they trusted the teacher, the
school, and the health personnel, arguing that if they had
approved the vaccination at the school then it was a good thing
for their daughters; this assessment was particularly true in rural
areas. Some parents stressed that they trusted the teachers at their
schools. Other parents responded to the advice given by the school
head teacher or administrative staff. Parents generally emphasized
the long experience of trust they had with these people and
institutions over the years. In some settings, however, parents
described schools where the teachers were not respected or the
parents always opposed what the teachers told them.
I had not heard of the vaccine for the cervix. For my part I
was afraid that it was going to be a dangerous thing because
sometimes they get vaccinated and sometimes they die, they
become ill or die. And that is the fear that I tell you about as
a mom, I was afraid to have them give her the vaccine. So
we did not want to accept it. Between us we wondered if it
would give a good result. We were so hesitant. The teacher
told us not to be afraid as the cervical cancer vaccine is
important to them. And we let ourselves be persuaded by the
teacher. (rural mother)
HPV vaccines are expensive, so we should take advantage
of the free opportunity. Many parents, especially those in
urban areas, mentioned that they decided to accept HPV
vaccination because it was being given free to 5th grade girls.
Since the vaccine was too expensive for them to afford through the
private sector, they did not want to miss this chance. Parents
learned about this opportunity from teachers, health personnel,
and their daughters.
Yes, they announced that it was a privilege to have the pilot
project start in the city, because the vaccine was very
expensive and they were giving it in areas with economic
shortages… Apart from the information they gave about
a better future, it was due to the part that they were helping
the population’s health by giving something that was so
expensive, making it free… and, well, if it doesn’t cost
anything for people with no resources, (you have to) take
advantage.’’ (urban mother)
Positive media reports about HPV vaccines. A multi-level
communication campaign was implemented in Piura. Local
communication strategies varied across the region. In one of the
rural mountainous zones, extensive dissemination about the HPV
vaccine was done through the municipality’s radio station and
through contacts with the local Catholic Church. At the mass-
media level, the press and television maintained attention on the
campaign through separate announcements of each of the three
doses of the HPV vaccine and regional news briefs. Some girls and
mothers reported having heard or seen news items on television.
Also at the mass-media level, campaign posters and banners were
displayed on the front of the health facilities and some schools.
Many mothers and girls mentioned having seen the banners,
which reassured them about the official nature of the vaccination
event.
Other parents, relatives, and health personnel were
supportive. After the informational meetings at schools, par-
ticularly in the urban areas, most parents discussed their thoughts
and doubts about the vaccine within their family and with other
parents. They also looked for additional information on the
Internet or sought medical advice from health professionals. Only
after they received a favorable opinion about the HPV vaccine
from this additional information did they agreed to vaccinate their
daughters.
Decision to vaccinate involved both parents. In both
urban and rural areas some mothers wanted to talk to their
husbands about the decision, even after they had decided that they
wanted to vaccinate their daughters. Some of these mothers
described their relationship with their husbands as one of trust and
communication, in which the husband trusted what she decided.
Other mothers explained the decision to vaccinate their daughter
was one they would make jointly with their husbands as it was of
particular importance.
Parental Acceptance of HPV Vaccine in Peru
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They gave us a piece of paper to sign and you had to tell
your husband about it. I explained to my husband what they
told us in the talk and we agreed to have her vaccinated…
he said it was OK for her to be vaccinated. If your husband
didn’t agree? They didn’t give her the vaccine, because if
something happened to her it was my responsibility; you
both had to agree.’’ (rural mother)
The fathers interviewed said that they heard about the
importance of the vaccination on their daughter’s future health
from their wife or daughter. Some fathers recommended that the
mother consult the teacher or health worker again just to be sure,
while others agreed with their wife or daughter’s inclination to
vaccinate. Some fathers also mentioned that because this was
a women’s health issue, it was more appropriate for mothers to
make this decision.
…I talked to my husband (…) the first thing he said to me
was, ‘‘Ask your sister to ask the doctors, to find out, because
I don’t know, I don’t really understand…’’ (urban mother)
Educational materials. For some parents, particularly in
urban areas, the educational leaflet distributed prior to vaccina-
tions provided important information about the vaccine and
helped them make their decision. They remembered the contents
of the leaflet described the purpose of the vaccine and recalled how
the illustrations included had explained the illness.
The influence of the girls eligible for vaccination. Some
mothers in urban areas said that it was their daughter who
convinced them to get the vaccine. Some daughters asked for
vaccination, in one case crying, concerned that she would get sick
or even die if she was not vaccinated.
Yes, she wanted to be vaccinated, and on top of that she’s
thin and told me the vaccine would surely make her put on
weight. She also said, ‘‘They’ve already vaccinated me
against hepatitis B and nothing happened to me; so, mom,
let me be vaccinated.’’ She’s not scared of vaccines. (urban
mother)
Factors for Non-acceptance of HPV Vaccine
Vaccine side effects. Some parents in both urban and rural
areas believed that a disease as serious as cervical cancer would
require an equally strong vaccine, and were concerned that
a vaccine of this strength could harm their daughters. Many
parents who did not accept HPV vaccine feared the vaccine would
cause sterilization or affect the normal development of the female
reproductive organs.
I was scared because she still isn’t menstruating. I said
perhaps it’s going to affect her menstruation. And I heard
somewhere that you end up sterile after having that vaccine.
(urban mother)
All of us moms said no because of the rumors about
sterilization, or the effects after applying vaccines, because
there was a rumor at the time about the hepatitis vaccine,
even that children had died because of the vaccine. So that
frightened us. (urban mother)
Consent for vaccination as a barrier. Some parents,
particularly those in urban areas, felt that signing an authorization
for their daughter to be vaccinated meant accepting responsibility
for any negative reaction to the vaccine. This consent process
generated distrust as consent had not been requested for other
vaccines.
The influence of the girl eligible for vaccination. In some
cases the parents wanted to vaccinate their daughter, but she did
not want to be vaccinated, claiming that it hurt a great deal. Some
parents mentioned that they did not insist on vaccination for this
reason.
My daughter did not want to be vaccinated, said flatly no.
And so daughter if you do not want it, I won’t force you. For
that reason I did not… (urban mother)
Absence of information about the HPV vaccine in the
mass media. Parents mentioned that a lack of information
about the HPV vaccine in the media increased their distrust as
they felt the vaccine campaign might be an experiment that was
being hidden or kept secret.
For the hepatitis B (vaccine) … we knew about it from the
media. We haven’t had complete knowledge about the
uterine cancer (vaccine) because we have seen the media and
there has been no information … I do not know where the
vaccine came from. The Ministry of Health always provides
information and in this case there wasn’t any … My
husband told me that they had told him they wanted to
sterilize girls.(He said)‘‘How do you know that these vaccines
are really for uterine cancer, or is it for something else?’’
(urban mother)
On the other hand, parents reported that they heard news
related to problems with other vaccines. In coastal urban and rural
zones in particular, parents mentioned in interviews that the
decision-making process was influenced by news stories related to
cases of vaccine-related death due to yellow fever or measles/
rubella vaccines and by news of expired vaccines in the area’s
health facilities. These reports generated a general fear of
vaccinating their daughters, and increasing distrust of the HPV
vaccine among parents.
We heard the news of a child who had been vaccinated in
Lima against hepatitis B and lost her ability to speak. So my
husband was afraid to vaccinate my daughter. (rural mother)
The role of fathers in authorizing health care for
something serious. Given the uncertainty and fears surround-
ing the vaccine, some mothers mentioned that they left the
decision in the hands of the girl’s father. In some cases, the mother
did not want the responsibility of making the decision about her
daughter’s vaccination, even when she herself wanted her
daughter to be vaccinated.
Her dad had to give the order. If her dad said yes, I said yes,
too. If he says no and I say yes, suppose something happened
to the baby. That’s why. (rural mother)
Vaccine may promote sexual promiscuity. In just one
family interviewed, one parent argued that the HPV vaccine
Parental Acceptance of HPV Vaccine in Peru
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would encourage their daughter to have sexual relations and
would have a negative effect on her health.
Her dad didn’t want to authorize it because he said it
encourages having sexual relations with anyone. I explained
to him that it was a vaccine to protect her against cervical
cancer, but he didn’t want to sign. He was also afraid
something might happen to her. (rural mother)
Limited or unclear information. Some parents mentioned
that they did not have enough information to make the decision
about vaccination, or felt the information they had received was
not sufficient. They cited not having any written material about
the HPV vaccine. Some said that they did not go to the
educational meeting for parents, but also did not receive other
information on the subject–or only received information through
their daughter. This was noted more commonly in urban than in
rural settings.
Discussion
The broader concept of prevention (cancer as a danger to be
avoided, future health of daughters, avoiding risks, and vaccines as
trusted strategy) combined with pragmatic factors (free, available
at school) and the credibility of the offer (information in the media,
recommendation of teacher or other respected authority figure)
were central among the multiple motivations that led parents to
choose to vaccinate their daughters against HPV. All these factors
have emerged previously in the literature. Women from a rural
area in North Carolina who associated negative consequences or
reported high perceptions of cervical cancer risk were more
accepting of the HPV vaccine [16]. Likewise a Swedish study
identified a parent’s attitude toward vaccination in general as
a correlate to their willingness to vaccinate their child against HPV
[17]. In a study of maternal acceptance of the HPV vaccine in
Malaysia, 98 percent of mothers said they would accept the
vaccine for their daughters if it was provided routinely by the
government [18]. Our findings of reasons for vaccination are also
confirmed from a quantitative study of HPV vaccine coverage in
Peru, India, Uganda, and Vietnam. More than two-thirds of
parents of fully vaccinated girls indicated that they had their
daughters vaccinated primarily for protection against cervical
cancer, or because they believed that vaccines are good for health
[19]. The HPV vaccine’s benefit for the prevention of cervical
cancer has been noted in studies done in the United Kingdom and
Australia, after they introduce HPV vaccine as a part of the
national immunization program [20,21].
Parents in our study also emphasized the importance of
information and its provision through multiple trusted channels.
Mass media was considered an important source of information
about this and other vaccines, and lack of information about the
HPV vaccine led to suspicion. Latina immigrants in a study of
HPV vaccine in the United States reflected a similar sentiment in
emphatically articulating that, to encourage others to get the HPV
vaccine, more than one credible source of information would be
needed [22]. Similarly, in a study of Salvadoran women and
Latina women living in the United States, information was of the
utmost importance. Among those who were unsure or would
refuse the HPV vaccine, the most common reasons were ‘‘Because
I don’t know enough about HPV’’ and ‘‘I want to talk to my
child’s doctor first’’ [23].
We identified a lack of confidence in the health system as the
primary inhibitor of vaccine acceptance. Some parents expressed
this lack of confidence as fears about side effects such as
sterilization, while others reported they did not have enough
information to make a decision. These reasons are similar to those
reported in a study of vaccine acceptance in the United Kingdom,
where the main reason cited by parents was insufficient in-
formation about the vaccine and its long-term safety [20]. This
finding parallels a survey of HPV coverage in Vietnam, where
concerns about the safety of the vaccine and its possible
experimental nature emerged, particularly in one urban location
[19].
Concerns about vaccine safety have been increasing and other
studies have revealed it is an important barrier to vaccination. A
study of knowledge and attitudes about HPV and cervical cancer
among adult women in northern Lima, Peru, found high levels of
vaccine acceptability; however, worry about whether the vaccine
was safe for use was an issue for 82 percent of respondents [24]. A
study in Sweden found that adverse effects from the vaccine were
the primary concern of Swedish parents in their unwillingness to
vaccinate their children against HPV [17], which is similar to
sentiments from Malaysian mothers [18].
While one parent cited fears of the vaccine causing early sexual
activity, this issue was notably absent from most of the discourse of
parents. A systematic review of the literature in 2007 identified
four quantitative studies that addressed this issue; the authors
found that only 6–12 percent of parents endorsed this concern
[25]. Ferris and colleagues studied sexual disinhibition among 325
parents of children aged 9–17 years and found only 17 (5%) who
thought that receiving HPV vaccine would encourage their child
to have sex [26].
The HPV vaccine is different from most vaccines in the
childhood vaccination schedule because it is recommended for
girls aged 9213 years, prior to sexual debut. However girls of this
age often start expressing their own agency [27], an issue that is
simply not part of the equation when parents are considering
vaccinating infants. We observed that the HPV vaccine decision
was not solely that of parents, but that the girl herself sometimes
also influenced the parents’ decision–both in accepting and in
rejecting the vaccine. In the previously cited study from the United
Kingdom, 70 percent of girls interviewed stated that the vaccine
decision was made jointly with her parents [28]. Studies from
Australia [21] and Uganda [27] also found that adolescents have
some independence in the decision to receive the HPV vaccine.
Combined, these studies provide mounting evidence that decision-
making for HPV vaccination has some degree of negotiation
within the family, reflecting the maturation of adolescents and
their increased independence from parents as they age.
Our conceptual model shares some core components with that
developed from the work of Cooper Robbins and her colleagues
[29] from the HPV vaccination program in Australia. Like us, they
identified a framework in which some parents are decided and
others are indecisive regarding whether to accept the HPV
vaccine. They also identified the importance of parental
confidence (or lack thereof) in the school as well as in the medical
system. Their model differs from ours, however, in some key ways.
Their model highlighted the individual family decision, whereas
we observed that families in Peru reacted strongly in relation to the
context of the provision of the vaccine. We identified the
important contextual factor of teachers, health personnel, other
parents, and the Internet in a central influential role–particularly
in urban environments. Unlike the Australian model, we identified
differences in the context of decision-making between urban and
rural environments. In rural areas the parents were less decisive,
while in urban areas they consulted with more people they trusted
and took more time to come to a decision. In our model, the
concerns of parents who did not accept vaccination were not as
Parental Acceptance of HPV Vaccine in Peru
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related to the sexual fate of their daughters (that it would
encourage sexual depravity), but were rather about reproductive
destiny: concerns about sterility or that the vaccine might be an
experiment–essentially a core distrust of the government’s health
system.
Lastly, we should note that the vaccine coverage achieved
through this school-based HPV vaccination demonstration project
in Piura, Peru, was quite high at 82.6 percent [19]. Indeed,
vaccine coverage has been perceived to be the ultimate marker of
acceptability, as a large proportion of the population agreeing to
be vaccinated would signal broad support in the community. The
preparations to implement the vaccination program in Piura could
have influenced its feasibility [13], and in turn the acceptability to
parents found in our study. The dynamic interplay between
program preparations and community mobilization with program
implementation and health worker competence has been noted in
studies of the HPV vaccination program rolled out in Australia
[29].
Limitations
This study was limited in its relatively small sample size and
geographic coverage of a single region within Peru. The study also
took place in the context of a demonstration project rather than
national implementation of the HPV vaccine. Some of the issues
that emerged in this context may not be relevant to broad
implementation of the vaccine. Nonetheless, the rich qualitative
detail gives insights that may be relevant in a range of other
settings, and the themes found in this study are echoed in
quantitative data from other studies.
Conclusions
This study identified a number of specific conditions that were
important in the process of parental acceptance of the HPV
vaccine in Peru, many of which may be relevant to other countries
considering adoption of the vaccine.
Access to information is essential. Parents and girls themselves
needed access to information that addressed their questions and
allowed them to make informed decisions. Health personnel
should be aware that vaccination of school-aged girls is not the
same as infant vaccinations, in that girls this age are able to express
their own opinions about vaccination and few vaccinations are
delivered to children in this age group. Health personnel should be
prepared to discuss these issues with parents and the girls.
Teachers were also a trusted source of information for many
parents, and programs may want to make sure that teachers
understand the issues related to HPV vaccination and are
prepared to share those details with parents and students.
Positioning of the HPV vaccine is important. Positioning the
vaccine as an approach to combating cervical cancer strengthened
parent confidence and helped parents to feel secure in their
decision to improve the future health of their daughters. Programs
will want to consider how to support parents in making good
decisions for their daughter’s health. A focus on prevention may be
useful in supporting parents in their decision-making.
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